AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 11182217 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin therapy
Number of subjects: 1290
Study 9018611 — intervention group
Group type: EXPERIMENTAL
Intervention: Grip exercise
Number of subjects: 14
Study 9018611 — intervention group
Group type: EXPERIMENTAL
Intervention: Push-up exercise
Number of subjects: 14
Study 7877434 — intervention group
Group type: EXPERIMENTAL
Intervention: Alpha interferon treatment
Number of subjects: 24
Study 3236746 — intervention group
Group type: EXPERIMENTAL
Intervention: Tono-Pen (TP)
Number of subjects: 108
Study 3236746 — intervention group
Group type: COMPARATOR
Intervention: Goldmann tonometer (GM)
Number of subjects: 108
Study 3236746 — intervention group
Group type: EXPERIMENTAL
Intervention: Tono-Pen (TP) and Goldmann tonometer (GM)
Number of subjects: 108
Study 30276771 — intervention group
Group type: EXPERIMENTAL
Intervention: Chan-Chuang qigong intervention for three months
Number of subjects: 100
Study 30276771 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 100
Study 28959158 — intervention group
Group type: EXPERIMENTAL
Intervention: Pre-workout supplement (PWS) - Reckless™
Number of subjects: 30
Study 28959158 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PBO) - maltodextrin and glycine
Number of subjects: 30
Study 23089176 — intervention group
Group type: EXPERIMENTAL
Intervention: Pregabalin
Number of subjects: 80
Study 23089176 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of pregabalin, cetirizine, and pheniramine maleate
Number of subjects: 80
Study 23089176 — intervention group
Group type: COMPARATOR
Intervention: Antihistaminic combination (cetirizine with pheniramine maleate)
Number of subjects: 80
Study 23089176 — intervention group
Group type: COMPARATOR
Intervention: Placebo (vit. B comp.)
Number of subjects: 80
Study 23089176 — intervention group
Group type: EXPERIMENTAL
Intervention: Massage with coconut oil
Number of subjects: 80
Study 21647425 — intervention group
Group type: EXPERIMENTAL
Intervention: Polypill (aspirin 75 mg, lisinopril 10 mg, hydrochlorothiazide 12.5 mg and simvastatin 20 mg)
Number of subjects: 378
Study 21647425 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 378
Study 19665601 — intervention group
Group type: EXPERIMENTAL
Intervention: lasofoxifene (0.25 mg/d)
Number of subjects: 51
Study 16734920 — intervention group
Group type: EXPERIMENTAL
Intervention: Carer-held records (CHR)
Number of subjects: 84
Study 16734920 — intervention group
Group type: COMPARATOR
Intervention: Control group (no CHR)
Number of subjects: 84
Study 15324987 — intervention group
Group type: EXPERIMENTAL
Intervention: Computer-based interactive training program (CBITP)
Number of subjects: 64
Study 15324987 — intervention group
Group type: COMPARATOR
Intervention: Conventional training (written instructions)
Number of subjects: 64
Study 11388226 — intervention group
Group type: COMPARATOR
Intervention: Medtronic Freestyle valve (group F)
Number of subjects: 37
Study 11388226 — intervention group
Group type: EXPERIMENTAL
Intervention: Homograft (group H)
Number of subjects: 37
Study 9140673 — intervention group
Group type: EXPERIMENTAL
Intervention: Bunazosin (6 and 12 mg once daily for 12 weeks)
Number of subjects: 32
Study 9140673 — intervention group
Group type: COMPARATOR
Intervention: Atenolol (50 and 100 mg once daily for 12 weeks)
Number of subjects: 32
Study 7952624 — intervention group
Group type: EXPERIMENTAL
Intervention: Breathing 60% O2 during exercise
Number of subjects: 7
Study 7952624 — intervention group
Group type: COMPARATOR
Intervention: Breathing room air (RA)
Number of subjects: 7
Study 3136279 — intervention group
Group type: EXPERIMENTAL
Intervention: naaga (magnesium salt of N‐acetyl aspartyl glutamic acid‐rhinaaxia)
Number of subjects: 91
Study 3136279 — intervention group
Group type: COMPARATOR
Intervention: disodium cromoglycate (LOMUPREN)
Number of subjects: 91
Study 31747840 — intervention group
Group type: EXPERIMENTAL
Intervention: Nintedanib (Ofev™)
Number of subjects: 0
Study 31747840 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 30852481 — intervention group
Group type: EXPERIMENTAL
Intervention: Fructus akebiae extract combined with ursodeoxycholic acid (UDCA)
Number of subjects: 180
Study 30852481 — intervention group
Group type: COMPARATOR
Intervention: ursodeoxycholic acid (UDCA)
Number of subjects: 180
Study 29423403 — intervention group
Group type: EXPERIMENTAL
Intervention: Amoxicillin + clavulanic acid (1 gr. tablet given 12 hours and 1 hour before surgery)
Number of subjects: 34
Study 29423403 — intervention group
Group type: COMPARATOR
Intervention: Control group (no antibiotic prophylaxis)
Number of subjects: 34
Study 26699529 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefepime (50 mg/kg up to 2 g single dose perioperative intravenous infusion)
Number of subjects: 230
Study 26699529 — intervention group
Group type: COMPARATOR
Intervention: Ceftriaxone (50 mg/kg up to 2 g single dose perioperative intravenous infusion)
Number of subjects: 230
Study 23322359 — intervention group
Group type: EXPERIMENTAL
Intervention: Cued recall with fewer categories (2 categories)
Number of subjects: 0
Study 23322359 — intervention group
Group type: EXPERIMENTAL
Intervention: Cued recall with more categories (24 categories)
Number of subjects: 0
Study 23322359 — intervention group
Group type: EXPERIMENTAL
Intervention: Rote repetition with fewer categories (2 categories)
Number of subjects: 0
Study 23322359 — intervention group
Group type: EXPERIMENTAL
Intervention: Interactive imagery with fewer categories (2 categories)
Number of subjects: 0
Study 23322359 — intervention group
Group type: EXPERIMENTAL
Intervention: Free recall with fewer categories (2 categories)
Number of subjects: 0
Study 23322359 — intervention group
Group type: EXPERIMENTAL
Intervention: Cued recall with more categories (20 categories)
Number of subjects: 0
Study 21214368 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-level laser therapy (LLLT) (685 nm, energy density 10 J/cm(2)) in addition to conventional therapy
Number of subjects: 23
Study 21214368 — intervention group
Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 23
Study 18156492 — intervention group
Group type: EXPERIMENTAL
Intervention: t(9;22)/BCR/ABL1
Number of subjects: 200
Study 18156492 — intervention group
Group type: EXPERIMENTAL
Intervention: other unfavorable karyotypes
Number of subjects: 200
Study 18156492 — intervention group
Group type: COMPARATOR
Intervention: normal diploid group
Number of subjects: 200
Study 18156492 — intervention group
Group type: EXPERIMENTAL
Intervention: miscellaneous group
Number of subjects: 200
Study 18156492 — intervention group
Group type: EXPERIMENTAL
Intervention: age
Number of subjects: 200
Study 21254854 — intervention group
Group type: EXPERIMENTAL
Intervention: PUVA therapy
Number of subjects: 88
Study 21254854 — intervention group
Group type: COMPARATOR
Intervention: Topical steroids
Number of subjects: 88
Study 15620772 — intervention group
Group type: EXPERIMENTAL
Intervention: Chesterfield stent for palatal endosseous implant placement
Number of subjects: 0
Study 12883396 — intervention group
Group type: EXPERIMENTAL
Intervention: Endotracheal Tube (ETT)
Number of subjects: 14
Study 12883396 — intervention group
Group type: COMPARATOR
Intervention: Laryngeal Mask Airway (LMA)
Number of subjects: 14
Study 9797758 — intervention group
Group type: EXPERIMENTAL
Intervention: High dose inhaled beclomethasone dipropionate (BDP) 500 micrograms three times daily for two months
Number of subjects: 34
Study 9797758 — intervention group
Group type: COMPARATOR
Intervention: Nothing (control group)
Number of subjects: 34
Study 9797758 — intervention group
Group type: EXPERIMENTAL
Intervention: High dose inhaled beclomethasone dipropionate (BDP)
Number of subjects: 34
Study 7544851 — intervention group
Group type: EXPERIMENTAL
Intervention: Consolidation Arm A: cytosine arabinoside 200 mg/m2 daily for 7 days and daunorubicin 45 mg/m2 daily for 3 days for three courses
Number of subjects: 398
Study 7544851 — intervention group
Group type: EXPERIMENTAL
Intervention: Consolidation Arm B: one course as in Arm A followed by amsacrine 120 mg/m2 daily for 5 days and a 5-day continuous infusion of azacytidine 150 mg/m2/day
Number of subjects: 398
Study 7544851 — intervention group
Group type: EXPERIMENTAL
Intervention: Consolidation Arm C: thioguanine and cytosine arabinoside 100 mg/m2 every 12 h and daunorubicin 10 mg/m2 daily for 5 days for three courses followed by four maintenance courses of cytosine arabinoside 100 mg/m2 daily for 5 days and daunorubicin 45 mg/m2 for 2 days every 13 weeks
Number of subjects: 398
Study 7544851 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive consolidation therapy with the same or different drugs used in induction
Number of subjects: 398
Study 2910220 — intervention group
Group type: EXPERIMENTAL
Intervention: Clomipramine hydrochloride
Number of subjects: 10
Study 2910220 — intervention group
Group type: EXPERIMENTAL
Intervention: Metergoline
Number of subjects: 10
Study 2910220 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 1207432 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental group (fatigued)
Number of subjects: 60
Study 1207432 — intervention group
Group type: COMPARATOR
Intervention: Control group (not fatigued)
Number of subjects: 60
Study 30158516 — intervention group
Group type: EXPERIMENTAL
Intervention: Very high-protein and low-carbohydrate enteral nutrition formula
Number of subjects: 12
Study 30158516 — intervention group
Group type: COMPARATOR
Intervention: Very high-protein and higher-carbohydrate formula
Number of subjects: 12
Study 30158516 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin response
Number of subjects: 12
Study 28558160 — intervention group
Group type: EXPERIMENTAL
Intervention: 6-month exercise training program (RYGB+EX)
Number of subjects: 96
Study 28558160 — intervention group
Group type: COMPARATOR
Intervention: lifestyle educational classes (RYGB)
Number of subjects: 96
Study 25850463 — intervention group
Group type: EXPERIMENTAL
Intervention: Anapen
Number of subjects: 158
Study 25850463 — intervention group
Group type: EXPERIMENTAL
Intervention: EpiPen
Number of subjects: 158
Study 25850463 — intervention group
Group type: EXPERIMENTAL
Intervention: Auvi-Q
Number of subjects: 158
Study 25850463 — intervention group
Group type: COMPARATOR
Intervention: Other devices (not specified)
Number of subjects: 158
Study 22845185 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcutaneous Triptorelin acetate (0.1 mg/m(2), to a maximum of 0.1 mg)
Number of subjects: 46
Study 22845185 — intervention group
Group type: COMPARATOR
Intervention: Intravenous GnRH 100 μg
Number of subjects: 46
Study 21527478 — intervention group
Group type: EXPERIMENTAL
Intervention: Parent testimonials
Number of subjects: 143
Study 21527478 — intervention group
Group type: EXPERIMENTAL
Intervention: Expert testimonials
Number of subjects: 143
Study 21527478 — intervention group
Group type: COMPARATOR
Intervention: No testimonial condition
Number of subjects: 143
Study 21527478 — intervention group
Group type: EXPERIMENTAL
Intervention: Expert testimonials framed in fear context
Number of subjects: 143
Study 21527478 — intervention group
Group type: EXPERIMENTAL
Intervention: Expert testimonials framed in non-fear context
Number of subjects: 143
Study 18443672 — intervention group
Group type: EXPERIMENTAL
Intervention: Controlled-release (CR) tramadol 200 mg, titrated to a maximum of 400 mg per day
Number of subjects: 97
Study 18443672 — intervention group
Group type: COMPARATOR
Intervention: Sustained-release (SR) diclofenac 75 mg, titrated to a maximum of 100 mg once daily or 75 mg twice a day
Number of subjects: 97
Study 17059314 — intervention group
Group type: EXPERIMENTAL
Intervention: Nostalgia
Number of subjects: 0
Study 17059314 — intervention group
Group type: EXPERIMENTAL
Intervention: Negative mood and loneliness triggers
Number of subjects: 0
Study 17059314 — intervention group
Group type: EXPERIMENTAL
Intervention: Nostalgic experiences
Number of subjects: 0
Study 14616354 — intervention group
Group type: EXPERIMENTAL
Intervention: Imiquimod 5% cream
Number of subjects: 10
Study 14616354 — intervention group
Group type: COMPARATOR
Intervention: Vehicle
Number of subjects: 10
Study 11475496 — intervention group
Group type: EXPERIMENTAL
Intervention: Enoxaparin 40 mg
Number of subjects: 1102
Study 11475496 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1102
Study 11475496 — intervention group
Group type: EXPERIMENTAL
Intervention: Enoxaparin
Number of subjects: 1102
Study 11475496 — intervention group
Group type: EXPERIMENTAL
Intervention: Unfractionated heparin
Number of subjects: 1102
Study 9130360 — intervention group
Group type: COMPARATOR
Intervention: Traditional didactic lecture mode (control group)
Number of subjects: 219
Study 9130360 — intervention group
Group type: EXPERIMENTAL
Intervention: Role plays and audiotaped feedback
Number of subjects: 219
Study 9130360 — intervention group
Group type: EXPERIMENTAL
Intervention: Role plays with peer feedback
Number of subjects: 219
Study 9130360 — intervention group
Group type: EXPERIMENTAL
Intervention: Video feedback
Number of subjects: 219
Study 1571904 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyperfractionated radiation therapy (HFX) with total doses of 6720, 7200, 7680, and 8160 cGy, using 120 cGy twice daily, 5 days per week.
Number of subjects: 233
Study 1571904 — intervention group
Group type: COMPARATOR
Intervention: Delays of 5 days or more in treatment.
Number of subjects: 233
Study 6463064 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 g cephradine
Number of subjects: 48
Study 6463064 — intervention group
Group type: COMPARATOR
Intervention: 500 mg flucloxacillin plus 500 mg ampicillin
Number of subjects: 48
Study 29582946 — intervention group
Group type: EXPERIMENTAL
Intervention: High dose cannabis (6 patients)
Number of subjects: 27
Study 29582946 — intervention group
Group type: EXPERIMENTAL
Intervention: Low dose cannabis (8 patients)
Number of subjects: 27
Study 29582946 — intervention group
Group type: COMPARATOR
Intervention: Active placebo (6 patients)
Number of subjects: 27
Study 29582946 — intervention group
Group type: COMPARATOR
Intervention: Placebo (7 patients)
Number of subjects: 27
Study 27394691 — intervention group
Group type: EXPERIMENTAL
Intervention: Slow loaded sit-to-stand exercise
Number of subjects: 16
Study 27394691 — intervention group
Group type: COMPARATOR
Intervention: Self-paced loaded sit-to-stand exercise
Number of subjects: 16
Study 26441181 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic lavage
Number of subjects: 199
Study 26441181 — intervention group
Group type: COMPARATOR
Intervention: Colon resection
Number of subjects: 199
Study 25016757 — intervention group
Group type: EXPERIMENTAL
Intervention: Narrowband UVB therapy for 12 weeks
Number of subjects: 0
Study 25016757 — intervention group
Group type: EXPERIMENTAL
Intervention: Erythmogenic strategy
Number of subjects: 0
Study 25016757 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment
Number of subjects: 0
Study 25016757 — intervention group
Group type: COMPARATOR
Intervention: Suberythmogenic strategy
Number of subjects: 0
Study 20859298 — intervention group
Group type: EXPERIMENTAL
Intervention: Unprocessed Fabuless
Number of subjects: 24
Study 20859298 — intervention group
Group type: EXPERIMENTAL
Intervention: Processed Fabuless
Number of subjects: 24
Study 20859298 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 24
Study 20859298 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-reported appetite scores
Number of subjects: 24
Study 18756957 — intervention group
Group type: EXPERIMENTAL
Intervention: Fibroid pedicle ligation (Group A)
Number of subjects: 280
Study 18756957 — intervention group
Group type: EXPERIMENTAL
Intervention: Injected with 12 IU diluted vasopressin around the myoma (Group B)
Number of subjects: 280
Study 18756957 — intervention group
Group type: EXPERIMENTAL
Intervention: Injected with 20 IU oxytocin combined with pedicle ligation (Group C)
Number of subjects: 280
Study 18756957 — intervention group
Group type: EXPERIMENTAL
Intervention: Injected with vasopressin combined with pedicle ligation (Group D)
Number of subjects: 280
Study 17054789 — intervention group
Group type: EXPERIMENTAL
Intervention: Risperidone
Number of subjects: 381
Study 17054789 — intervention group
Group type: EXPERIMENTAL
Intervention: Quetiapine
Number of subjects: 381
Study 17054789 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 381
Study 15831780 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefpodoxime (400 mg)
Number of subjects: 0
Study 15831780 — intervention group
Group type: COMPARATOR
Intervention: Cefixime (400 mg)
Number of subjects: 0
Study 11572104 — intervention group
Group type: EXPERIMENTAL
Intervention: New cognitive-emotional cognitive-behavioral therapy programmes (experimental group)
Number of subjects: 0
Study 11572104 — intervention group
Group type: COMPARATOR
Intervention: Traditional social skills training programme (control group, IPT 'Social Skills' subprogramme)
Number of subjects: 0
Study 9815827 — intervention group
Group type: EXPERIMENTAL
Intervention: MRP expression (low, intermediate, high)
Number of subjects: 80
Study 9815827 — intervention group
Group type: EXPERIMENTAL
Intervention: P-glycoprotein-positive AML
Number of subjects: 80
Study 7703703 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol and Behavioral Marital Therapy (ABMT)
Number of subjects: 105
Study 7703703 — intervention group
Group type: EXPERIMENTAL
Intervention: ABMT plus Alcoholics Anonymous and Alanon (AA/ABMT)
Number of subjects: 105
Study 7703703 — intervention group
Group type: EXPERIMENTAL
Intervention: ABMT plus Relapse Prevention (RP/ABMT)
Number of subjects: 105
Study 7703703 — intervention group
Group type: COMPARATOR
Intervention: Early treatment dropouts
Number of subjects: 105
Study 7703703 — intervention group
Group type: COMPARATOR
Intervention: Partial completers
Number of subjects: 105
Study 3477353 — intervention group
Group type: EXPERIMENTAL
Intervention: Special caries preventive program with controlled antimicrobial treatment using Streptococcus mutans as an indicator organism.
Number of subjects: 101
Study 3477353 — intervention group
Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned).
Number of subjects: 101
Study 31898212 — intervention group
Group type: EXPERIMENTAL
Intervention: Atypical anti-psychotics
Number of subjects: 992
Study 31898212 — intervention group
Group type: EXPERIMENTAL
Intervention: Typical anti-psychotics
Number of subjects: 992
Study 31898212 — intervention group
Group type: EXPERIMENTAL
Intervention: Selective-serotonin reuptake inhibitors (SSRIs)
Number of subjects: 992
Study 31898212 — intervention group
Group type: EXPERIMENTAL
Intervention: Serotonin-norepinephrine reuptake inhibitors (SNRIs)
Number of subjects: 992
Study 31898212 — intervention group
Group type: EXPERIMENTAL
Intervention: Tricyclic anti-depressants (TCAs)
Number of subjects: 992
Study 31898212 — intervention group
Group type: EXPERIMENTAL
Intervention: Atypical anti-depressants
Number of subjects: 992
Study 31898212 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination anti-depressants
Number of subjects: 992
Study 31898212 — intervention group
Group type: EXPERIMENTAL
Intervention: Benzodiazepines
Number of subjects: 992
Study 31898212 — intervention group
Group type: EXPERIMENTAL
Intervention: SSRIs
Number of subjects: 992
Study 31898212 — intervention group
Group type: EXPERIMENTAL
Intervention: SNRIs
Number of subjects: 992
Study 31898212 — intervention group
Group type: EXPERIMENTAL
Intervention: TCAs
Number of subjects: 992
Study 31898212 — intervention group
Group type: EXPERIMENTAL
Intervention: Anti-convulsants
Number of subjects: 992
Study 31898212 — intervention group
Group type: EXPERIMENTAL
Intervention: Lithium
Number of subjects: 992
Study 31898212 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of antipsychotics and anti-depressants
Number of subjects: 992
Study 30516172 — intervention group
Group type: COMPARATOR
Intervention: Environmental noise with alarm sounds (C3)
Number of subjects: 15
Study 30516172 — intervention group
Group type: COMPARATOR
Intervention: Environmental noise without alarm sounds (C2)
Number of subjects: 15
Study 30516172 — intervention group
Group type: COMPARATOR
Intervention: Standard condition (C1)
Number of subjects: 15
Study 27655384 — intervention group
Group type: EXPERIMENTAL
Intervention: Anodal transcranial direct current stimulation (tDCS) targeting the right temporoparietal area for 20 minutes
Number of subjects: 0
Study 27655384 — intervention group
Group type: COMPARATOR
Intervention: Cathodal transcranial direct current stimulation (tDCS) targeting the right temporoparietal area
Number of subjects: 0
Study 27655384 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation targeting the right temporoparietal area
Number of subjects: 0
Study 26578205 — intervention group
Group type: EXPERIMENTAL
Intervention: ENVIE program (add-on intervention)
Number of subjects: 332
Study 26578205 — intervention group
Group type: COMPARATOR
Intervention: Waiting list (control)
Number of subjects: 332
Study 24244687 — intervention group
Group type: EXPERIMENTAL
Intervention: lenalidomide
Number of subjects: 0
Study 21164120 — intervention group
Group type: EXPERIMENTAL
Intervention: Standardized measurement methods and training of therapist assessors
Number of subjects: 15
Study 19061746 — intervention group
Group type: EXPERIMENTAL
Intervention: Telemedicine intervention (8 weekly sessions in the first 2 months, followed by biweekly sessions for 4 months)
Number of subjects: 0
Study 19061746 — intervention group
Group type: COMPARATOR
Intervention: Standard care (control group)
Number of subjects: 0
Study 19061746 — intervention group
Group type: EXPERIMENTAL
Intervention: Telemedicine intervention
Number of subjects: 0
Study 16547994 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral fluid intake
Number of subjects: 524
Study 16547994 — intervention group
Group type: COMPARATOR
Intervention: Before hydration
Number of subjects: 524
Study 12665978 — intervention group
Group type: EXPERIMENTAL
Intervention: Sub-maximal inertial contractions at 20%, 30%, 40%, 50%, 60%, 70%, 80%, and 90% of their 1-RM
Number of subjects: 30
Study 12665978 — intervention group
Group type: EXPERIMENTAL
Intervention: Sub-maximal inertial contractions at various intensities
Number of subjects: 30
Study 12665978 — intervention group
Group type: EXPERIMENTAL
Intervention: Comparison of absolute and relative mass lifted
Number of subjects: 30
Study 12665978 — intervention group
Group type: EXPERIMENTAL
Intervention: Perceived exertion response to relative load
Number of subjects: 30
Study 10355012 — intervention group
Group type: EXPERIMENTAL
Intervention: 5% EMLA cream
Number of subjects: 0
Study 10355012 — intervention group
Group type: EXPERIMENTAL
Intervention: 1% dyclonine
Number of subjects: 0
Study 10355012 — intervention group
Group type: EXPERIMENTAL
Intervention: 10% benzocaine
Number of subjects: 0
Study 10355012 — intervention group
Group type: COMPARATOR
Intervention: 10% cocaine
Number of subjects: 0
Study 10355012 — intervention group
Group type: COMPARATOR
Intervention: 10% lidocaine
Number of subjects: 0
Study 10355012 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0